CorInnova, Inc.

JLABS @ TMC

2450 Holcombe Blvd. Suite J

Houston, Texas 77021

Phone: (346) 772-0345

Email: info@corinnova.com

© 2018 CorInnova. All Rights Reserved.

FOLLOW US:

  • LinkedIn Social Icon
  • Twitter Social Icon
Please reload

Advisors

_____

Dr. William Abraham

Dr. William T. Abraham, MD, FACP, FACC, FAHA, FESC is the independent member of the joint Wellcome Trust - CorInnova Research Steering Group (RSG). Dr. Abraham is director of the Division of Cardiovascular Medicine and a professor of internal medicine, physiology and cell biology at The Ohio State University Medical Center. He also serves as deputy director of Ohio State’s Dorothy M. Davis Heart and Lung Research Institute. Dr. Abraham is an internationally known researcher in heart failure. Dr. Abraham has received grants from the National Institutes of Health, the American College of Cardiology, etc. and has participated as principal investigator in more than 100 multicenter clinical drug and device trials. In addition to authoring more than 600 original papers, abstracts, book chapters and review articles, Dr. Abraham also co-edited Heart Failure: A Practical Approach to Treatment, a leading textbook on heart failure.

Dr. Susan Alpert

Susan Alpert, Ph.D., M.D. is a member of CorInnova's Advisory Board.  Dr. Alpert is currently the principle of SFA Regulatory, LLC.  She was Corporate Senior Vice President for Global Regulatory at Medtronic, Inc. and prior to that VP Regulatory Science at C.R. Bard, Inc. She previously worked at the US FDA where she held a variety of management positions in the Centers including Director of the Office of Device Evaluation for seven years. She completed her undergraduate degree at Barnard College, Columbia University in New York City, and is a Pediatric Infectious Disease clinician with a PhD in Medical Microbiology from NYU and an MD from the University of Miami,who has experience in laboratory research and clinical trials.

Dr. Daniel Burkhoff

Dr. Daniel Burkhoff, MD, PhD, is Senior Scientific Advisor to CorInnova. He is Director of Heart Failure, Hemodynamics and Circulatory Support at the Cardiovascular Research Foundation Clinical Trials Center.  Dr. Burkhoff is the creator of the Harvi simulator, an interactive application that gives healthcare providers a better understanding of the fundamentals of hemodynamics. It was designed to help educate physicians at all levels of traning on hemodynamics and to assist them in predicting the effects of different therapies, as well as aid in patient selection for new device therapies. Dr. Burkhoff has extensive hands-on experience with many cardiac assist technologies, including a prior generation of direct cardiac compression devices.   Dr. Burkhoff is an Adjunct Associate Professor of Columbia University, former Vice President Medical Science of HeartWare, and former Chief Medical Officer of CircuLite (next-gen LVAD company) and Cheetah Medical.

Dr. William Cohn

William E. Cohn, MD, CorInnova’s former Senior Clinical and Surgical Advisor and now informal advisor and RSG participant, is an internationally known cardiac surgeon, a medical device inventor, and serial entrepreneur.  In particular, Dr. Cohn has extensive experience with other passive cardiac support devices that contact the heart surface. Dr. Cohn is now Vice President for Medical Devices and Director of the Center for Device Innovation at J&J Innovation.  He was formerly at Texas Heart Institute (THI) as the Director of  Technology and Innovation and Director of the THI Cullen Cardiovascular Research Laboratory. He is a Professor of Surgery at Baylor College of Medicine.  Dr. Cohn conducted CorInnova’s’ series of nine large animal studies at the Texas Heart Institute in an ovine model of acute heart failure.

Julia Gregory

Julia Gregory, Advisory Board member, is Chairman and CEO of Isometry Advisors, Inc.   She is an experienced CEO, former CFO, and former health care investment banker.   Ms. Gregory is a proven leader who has built an impressive track record in leading and advising biotechnology companies over her decades-long career.  As a biotechnology executive, she has raised more than $2 billion for biotechnology companies across all types of business cycles and structured creative strategic alliances and transactions for them with major firms.

William Hunter

Dr. William Hunter, M.D. is a member of CorInnova's Advisory Board.  Dr. Hunter is President and CEO of Cardiome, a specialty pharma company. Prior to Cardiome, Dr. Hunter co-founded Angiotech in 1992 and became CEO in 1997 when Angiotech was a venture-stage, private, pre-clinical company with less than 50 employees.  He led Angiotech through three rounds of private equity financing, the Company's IPO, over $1 billion in equity and debt financings, a debt restructuring and eight separate corporate acquisitions. During that time, Angiotech grew to become a profitable, diversified, healthcare company with over 1,400 employees, 12 facilities in five countries and worldwide annual revenues exceeding $250 million.  Dr. Hunter has over 200 patents and patent applications to his name and products in which he was an inventor or co-inventor, including the TAXUS Drug-Eluting Coronary Stent.

Dr. Ulrich Jorde

Dr. Ulrich Jorde, Advisory Board member, is Director, Heart Failure and Advanced Cardiac Therapies, Vice Chief, Division of Cardiology of the Montefiore Medical Center and former Medical Director, Mechanical Circulatory Support, New York Presbyterian/Columbia University Medical Center.  A noted researcher, Dr. Jorde has extensively studied the impact of blood contact in various mechanical circulatory assist devices.

Dr. Dan Meyer

Dr. Dan Meyer is Chief of Cardiac Transplantation at Baylor Scott & White Health in Dallas, has worked with CorInnova on prior animal studies and advises on clinical study design.

Please reload